HIV resistance to lenacapavir weakens the virus's ability to replicate

Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...
eLife

HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir

In individuals who started antiretroviral therapy during acute HIV infection, the proliferative capacity of HIV-specific CD8+ ...
Science Daily

Scientists identify hidden protein interaction driving Parkinson’s disease

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...
KUNC

The near death -- and last-minute reprieve -- of a trial for an HIV vaccine

A trial was about to launch for a vaccine that would ward off the HIV virus. It would be an incredible breakthrough. Then it ...

Exploring mutations that spontaneously switch on a key brain cell receptor

Many people are familiar with histamine, a biological molecule that serves as a key driver of allergic reactions and other ...
Indy100 on MSN

A 'dopamine diet' could hold the key to improving your mood through food

A 'dopamine diet' could hold the key to improving your mood through food ...

Investigating HIV's hidden immune evasion strategy

A Northwestern Medicine study published in Nature Communications has revealed how HIV can protect infected cells by altering ...
Verywell Health

Proteinuria in Complement 3 Glomerulopathy: Why It Matters and What to Do

Proteinuria (protein in urine) is common with complement 3 glomeropathy and is a strong predictor of disease progression and end-stage kidney failure.
SciTech Daily

Johns Hopkins Scientists Identify Key Brain Protein That May Slow Alzheimer’s

Scientists are uncovering evidence that a subtle chemical process in the brain may be far more important to memory than previously recognized. When this process breaks down in mice, multiple systems ...